ExploreWatchlistsPricing
  1. JP-listed companies
  2. DAIICHI SANKYO COMPANY, LIMITED
  3. Financials
  4. Net income margin (%)

DAIICHI SANKYO COMPANY, LIMITED (4568)

Market cap
¥5.21T
P/E ratio
17.6x
Daiichi Sankyo is a global pharmaceutical company that researches, develops and sells prescription drugs and over-the-counter medicines worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202515.7+25.11%
Mar 31, 202412.5+46.74%
Mar 31, 20238.5+33.25%
Mar 31, 20226.4-18.78%
Mar 31, 20217.9-39.97%
Mar 31, 202013.1+30.85%
Mar 31, 201910+60.03%
Mar 31, 20186.3+12.15%
Mar 31, 20175.6-32.89%
Mar 31, 20168.3-76.19%
Mar 31, 201535+543.19%
Mar 31, 20145.4-15.10%
Mar 31, 20136.4+32.18%
Mar 31, 20124.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat